Japan Times Covers Rentosertib: AI-Discovered Lung Drug Reverses Aging Markers
Dr_Singularity · x · 2026-10-05
This post supplements the earlier rentosertib thread with a Japan Times/Bloomberg report: Insilico Medicine's AI-developed lung drug rentosertib reduced biological age across all six aging clocks in a midstage study, while the placebo group saw little change. Results were published in Nature Biotechnology.
CEO Alex Zhavoronkov notes that lower biological age predicts later death, while cautioning the findings remain early-stage. Same event as the main post; see that entry for details.
Related event: AI-Designed Drug Shows 3-4 Years of Biological Age Reversal in Human Trial(3 posts)→
More from Research
- Scientists open PRs on HF datasets: BIDS builder for neuroimaging and biosignals — evijit · 2026-11-20
- Hugging Hub science data formats mapped: AnnData leads genomics at 17% — evijit · 2026-11-20
- Fully AI-designed molecule Dyno-hc9: 7 mutations picked by deep learning, crosses blood-brain barrier — IAmSamFin · 2026-11-20
- Fine-tuned Qwen3-VL 8B reads camera shots at 69% accuracy, beating Opus and Gemini — ravisparikh · 2026-11-20
- Victor Taelin's Bend2 talk from SF Lean Meetup explains the rationale behind the language design — pbaylies · 2026-11-20
- Protocol Labs Launches Neuro Atlas: Companies, Milestones and BCI Funding Mapped — melnykowycz · 2026-11-20